UK Medicines Information
Revised SPC: Exemestane 25 mg Film-coated Tablets (Accord)
Information type:
Drug prescribing
Source:
Glenmark Pharmaceuticals Europe Ltd
Specialities:
Cancers
Summary
Section 4.4 (special warnings and precautions) now states that routine assessment of 25 hydroxy vitamin D levels prior to the start of aromatase inhibitor treatment should be considered, due to the high prevalence of severe deficiency in women with early breast cancer.
UKMi comment
Section 4.4 of the SPC for Aromasin does not currently include this information.
Related links: